bluebird bio (NASDAQ:BLUE) prices a 3.3M share offering at $76/share. • The offering was upsized to $250M from a previously disclosed $200M. • Goldman Sachs, BofA Merrill Lynch and Cowen & Co. are joint book-running managers of the offering. Wells Fargo Securities and Wedbush PacGrow are co-managers. • BLUE closed at $78.95.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.